These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3046820)

  • 1. Changes in thermal sensation in diabetic patients after treatment with gangliosides.
    Abraham RR; Levy DM; Abraham RM
    Diabetes Res; 1988 Mar; 7(3):129-35. PubMed ID: 3046820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.
    Ekberg K; Brismar T; Johansson BL; Lindström P; Juntti-Berggren L; Norrby A; Berne C; Arnqvist HJ; Bolinder J; Wahren J
    Diabetes Care; 2007 Jan; 30(1):71-6. PubMed ID: 17192336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganglioside therapy in diabetic neuropathy.
    Horowitz SH
    Muscle Nerve; 1986; 9(6):531-6. PubMed ID: 3526143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
    Jude EB; Selby PL; Burgess J; Lilleystone P; Mawer EB; Page SR; Donohoe M; Foster AV; Edmonds ME; Boulton AJ
    Diabetologia; 2001 Nov; 44(11):2032-7. PubMed ID: 11719835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganglioside therapy in experimental diabetic neuropathy.
    Spüler M; Dimpfel W; Tüllner HU
    Arzneimittelforschung; 1988 Jul; 38(7):881-4. PubMed ID: 3207433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
    Vinik AI; Bril V; Kempler P; Litchy WJ; Tesfaye S; Price KL; Bastyr EJ;
    Clin Ther; 2005 Aug; 27(8):1164-80. PubMed ID: 16199243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordance between different measures of small sensory and autonomic fibre neuropathy in diabetes mellitus.
    Westerman RA; Delaney C; Ivamy-Phillips A; Horowitz M; Roberts A
    Clin Exp Neurol; 1989; 26():51-63. PubMed ID: 2642139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.
    Brooks B; Delaney-Robinson C; Molyneaux L; Yue DK
    J Diabetes Complications; 2008; 22(2):88-95. PubMed ID: 18280438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganglioside (Cronassial) therapy in diabetic neuropathy.
    Horowitz SH
    Adv Exp Med Biol; 1984; 174():593-600. PubMed ID: 6377852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic neuropathy: electrophysiologic abnormalities of distal lower extremity sensory nerves.
    Izzo KL; Sobel E; Demopoulos JT
    Arch Phys Med Rehabil; 1986 Jan; 67(1):7-11. PubMed ID: 3942492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double blind placebo controlled trial of mixed gangliosides in diabetic peripheral and autonomic neuropathy.
    Abraham RR; Abraham RM; Wynn V
    Adv Exp Med Biol; 1984; 174():607-24. PubMed ID: 6331138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of three standard neurophysiological techniques in established symptomatic diabetic polyneuropathy.
    Krentz AJ; Honigsberger L; Nattrass M
    Diabetes Res; 1989 Nov; 12(3):135-9. PubMed ID: 2635095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electromyographic study of diabetic and alcoholic polyneuropathic patients treated with gangliosides.
    Bassi S; Albizzati MG; Calloni E; Frattola L
    Muscle Nerve; 1982; 5(5):351-6. PubMed ID: 6289096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial of ganglioside therapy for diabetic neuropathy.
    Hallett M; Flood T; Slater N; Dambrosia J
    Muscle Nerve; 1987; 10(9):822-5. PubMed ID: 3683453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-fibre involvement in diabetic patients with neuropathic foot pain.
    Vlckova-Moravcova E; Bednarik J; Belobradkova J; Sommer C
    Diabet Med; 2008 Jun; 25(6):692-9. PubMed ID: 18544107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of painful diabetic polyneuropathy with mixed gangliosides.
    Naarden A; Davidson J; Harris L; Moore J; DeFelice S
    Adv Exp Med Biol; 1984; 174():581-92. PubMed ID: 6331137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study.
    Goto Y; Hotta N; Shigeta Y; Sakamoto N; Kikkawa R
    Biomed Pharmacother; 1995; 49(6):269-77. PubMed ID: 7579007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus.
    Karsidag S; Morali S; Sargin M; Salman S; Karsidag K; Us O
    Diabetes Res Clin Pract; 2005 Mar; 67(3):211-9. PubMed ID: 15713353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of topical capsaicin on normal skin and affected dermatomes in herpes zoster.
    Westerman RA; Roberts RG; Kotzmann RR; Westerman DA; Delaney C; Widdop RE; Carter BE
    Clin Exp Neurol; 1988; 25():71-84. PubMed ID: 3267488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative sensory examination in diabetic children: assessment of thermal discrimination.
    Heimans JJ; Bertelsmann FW; de Beaufort CE; de Beaufort AJ; Faber YA; Bruining GJ
    Diabet Med; 1987; 4(3):251-3. PubMed ID: 2956030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.